MarketCap
Facebook
X
TelegramAnnual report 2023
added 12-13-2025
Centogene N.V. Operating Expenses 2011-2025 | CNTG
Annual Operating Expenses Centogene N.V.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 58 M | 42.1 M | 30.2 M | 21.3 M | 19.2 M | - | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 58 M | 19.2 M | 34.2 M |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
45.3 M | $ 0.23 | -5.27 % | $ 6.75 M |  USA |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 39.52 | -1.42 % | $ 1.1 B | USA |
 |
DarioHealth Corp.
DRIO
|
62.2 M | $ 10.11 | 0.67 % | $ 287 M |  Israel |
 |
DexCom
DXCM
|
1.69 B | $ 67.34 | -0.12 % | $ 26 B | USA |
 |
Brainsway Ltd.
BWAY
|
29.2 M | $ 19.45 | 0.83 % | $ 99.4 M | Israel |
 |
Burning Rock Biotech Limited
BNR
|
726 M | $ 20.3 | -4.29 % | $ 219 M |  China |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.51 | -0.83 % | $ 1.92 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
Danaher Corporation
DHR
|
6.71 B | $ 229.65 | -0.65 % | $ 168 B | USA |
 |
Exact Sciences Corporation
EXAS
|
2.98 B | $ 101.6 | 0.06 % | $ 18.8 B | USA |
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
181 M | $ 26.77 | -0.91 % | $ 809 M | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
Myriad Genetics
MYGN
|
709 M | $ 6.44 | -1.68 % | $ 583 M | USA |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
ENDRA Life Sciences
NDRA
|
10.8 M | $ 5.0 | -1.96 % | $ 2.68 M | USA |
 |
Neogen Corporation
NEOG
|
1.48 B | $ 7.04 | -1.47 % | $ 1.53 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
National Research Corporation
NRC
|
38.5 M | $ 18.45 | -1.07 % | $ 453 M | USA |
 |
CareDx, Inc
CDNA
|
484 M | $ 19.44 | -1.47 % | $ 1.05 B | USA |
 |
Celcuity
CELC
|
113 M | $ 101.85 | -0.74 % | $ 4.02 B | USA |
 |
Pacific Biosciences of California
PACB
|
387 M | $ 1.77 | -5.75 % | $ 449 M | USA |
 |
Anixa Biosciences
ANIX
|
9.98 M | $ 3.21 | -6.14 % | $ 102 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 26.96 | -0.07 % | $ 20 B |  Niderland |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
2.94 B | $ 225.82 | -0.09 % | $ 40.9 B | USA |
 |
Quidel Corporation
QDEL
|
285 M | $ 28.67 | -0.83 % | $ 1.21 B | USA |
 |
QIAGEN N.V.
QGEN
|
821 M | $ 45.35 | -0.29 % | $ 10.1 B | Niderland |
 |
Guardant Health
GH
|
226 M | $ 103.5 | 1.09 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Sotera Health Company
SHC
|
305 M | $ 17.67 | -0.17 % | $ 5 B | USA |
 |
Illumina
ILMN
|
3.69 B | $ 134.9 | -0.31 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
607 M | $ 202.44 | -0.35 % | $ 10.4 B | USA |
 |
Trinity Biotech plc
TRIB
|
28.3 M | $ 1.05 | 2.94 % | $ 61.9 M |  Irlanda |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 175.79 | -0.07 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
106 M | $ 6.66 | -2.35 % | $ 864 M | USA |
 |
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 253.43 | -0.4 % | $ 21.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 182.19 | -0.81 % | $ 15 B | Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.25 B | $ 686.71 | -0.21 % | $ 56.6 B | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 66.27 | -0.61 % | $ 4.59 B | USA |